David M. Maggio
Chief Financial OfficerMr. David M. Maggio, also known as Dave, serves as Chief Executive Officer of Bellicum Pharmaceuticals, Inc. since February 2, 2024. Mr. Maggio has broad domestic and global experience in executing financial advisory, turnaround and restructuring assignments, as well as strategically focused corporate finance and M&A projects. He is Chief Financial Officer of Nabriva Therapeutics plc from June 30, 2023. He serves as President and Secretary of Otonomy, Inc. since March 31, 2023. He serves as Chief Business Officer, President, Chief Executive Officer, Secretary, Treasurer, Principal Financial & Accounting. Officer of Metacrine, Inc. since March 24, 2023. He has served as a Director at Armanino in the firm’s Corporate Finance and Restructuring practice since November 2021. Previously, he was a Co-Founder of Omni Professional Services, LLC, a privately owned Investor in the sporting goods industry Headquartered in El Paso, Texas and has served as an Operating Partner at CornerPost Capital,Partners, LLC, a middle-market, private equity firm based in Dallas, Texas, since 2010. Mr. Maggio has served on the Board of Directors of TGE Industrial Services, LLC, a privately held company focused on servicing the petrochemical, refining, chemical and heavy manufacturing industries since 2013 and in late 2018, during his tenure as Chief Executive Officer, negotiated a strategic merger with an industry peer He serves as the Member of Board of Advisors at WorthPoint Corporation. Mr. Maggio serves as Legal Professional at Altius Capital LLC. He has experience in evaluating, structuring, negotiating and executing mergers & acquisitions, joint ventures and alliances, private financings in equity and debt and strategic advisory services. Mr. Maggio has specialized in advising private company’s and shareholders from the equity funding stage through the ultimate exit strategy development and execution. He has a broad range of industry experience and has advised both public and private companies on transactions and strategies in the U.S. Europe and Asia. Mr. Maggio has advised companies in the technology industries including semiconductor equipment, telecommunications, software and display technologies, as well as business services, retail, energy and industrial equipment. He was formerly the Chief Executive Officer of an Internet software development company and has held senior positions in regional investment banking organizations. Mr. Maggio was with Pricewaterhouse/PricewaterhouseCoopers, where he held senior executive positions in the Corporate Finance Advisory Services Group. At PW, he was on the senior leadership team that developed the global strategy for corporate finance services aimed at technology companies. Mr. Maggio established and ran the San Jose Technology Investment Banking Office and co-led the Houston Investment Banking Office. He serves as a Member of Board of Advisors at WorthPoint Corporation. He is a Certified Public Accountant. Mr. Maggio has a B.S. Degree in Accounting from Louisiana State University and completed the Northwestern/Kellogg Business School Executive Merger & Acquisitions Program.
Positions
- Company NameNabriva Therapeutics plcStock CodeNBRVFPositionChief Financial Officer
